Surgical options for atrial fibrillation, including ablation and LAA exclusion, are evolving as effective strategies for rhythm control and stroke prevention.
May support surgical AF ablation and LAA exclusion; leaves open randomized trials versus transcatheter approaches.
Atrial fibrillation (AF) is not benign and its prevalence is increasing. The two main goals in management of atrial fibrillation are to optimize hemodynamics through rate or rhythm control and to prevent systemic thrombo-embolism. To date, these two goals are still sub-optimally achieved, raising the need for alternative methods and strategies both pharmacologically and through interventions. In this review, we discuss surgical strategies of achieving both goals with insights on the evolution and potential future of these strategies.
No takes yet. Share an insight, caveat, or question.
Ramlawi et al. (2015) conducted a review in Atrial fibrillation. Surgical ablation and left atrial appendage exclusion vs. Transcatheter ablation and medical therapy was evaluated.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: